More meds doubling in price
Prices have ballooned by 100 percent or more for a growing number of drugs, according to a new study. In fact, the number of branded meds whose prices have grown that much could double this year from four years ago. In 2007, the average wholesale price of 26 brand-name meds jumped 100 percent or more in a single price increase, up from 15 in 2004. In the first half of 2008, 17 made that list.
Many of the price increases have come on drugs that treat rare but serious conditions. For example, Questcor Pharmaceuticals boosted the price of Acthar, which treats spasms in babies, to $23,000 from $1,650 a vial.
- read the story in USA Today
Related Articles:
Congress decries drug price-gouging
Obama, McCain united against drug costs
Americans prioritize medication prices
PBMs profit off expensive niche meds
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

